CIK 0001368514 · Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562590442
- Phone
- (201) 478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Regulation FD disclosure
- 8-K Event Auditor change
- SC 13G/A Stake Amended Statement of Ownership
- 4 Shares withheld for taxes COO and SVP, Compliance gave up 2,647 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 21,752 shares (to pay taxes)
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market sale Director sold 9,000 shares at $18.47 ($166,189)
- 144 Insider Sale of Securities
- 4 Open-market sale COO and SVP, Compliance sold 24,150 shares at $16.90 ($408,050)
- 4 Open-market sale Director sold 136,861 shares at $17.27 ($2,363,932)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale President and CEO sold 626,245 shares at an average $17.44 ($10,923,987)
- 4 Open-market sale Director sold 60,000 shares at $18.26 ($1,095,600)
- 144 Insider Sale of Securities
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes COO and SVP, Compliance gave up 2,502 shares (to pay taxes)
Page 8 of 50 · 1,000 filings